These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18592156)

  • 41. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
    Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing.
    Yau TO; Chan CY; Chan KL; Lee MF; Wong CM; Fan ST; Ng IO
    Oncogene; 2005 Feb; 24(9):1607-14. PubMed ID: 15580286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
    Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
    Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.
    Griffiths EA; Gore SD; Hooker C; McDevitt MA; Karp JE; Smith BD; Mohammad HP; Ye Y; Herman JG; Carraway HE
    Leuk Lymphoma; 2010 Sep; 51(9):1711-9. PubMed ID: 20795789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis.
    Veeck J; Geisler C; Noetzel E; Alkaya S; Hartmann A; Knüchel R; Dahl E
    Carcinogenesis; 2008 May; 29(5):991-8. PubMed ID: 18356147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylation of SFRP5 is related to multidrug resistance in leukemia cells.
    Wang H; Wang X; Hu R; Yang W; Liao A; Zhao C; Zhang J; Liu Z
    Cancer Gene Ther; 2014 Feb; 21(2):83-9. PubMed ID: 24434572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sfrp1, Sfrp2, and Sfrp5 regulate the Wnt/beta-catenin and the planar cell polarity pathways during early trunk formation in mouse.
    Satoh W; Matsuyama M; Takemura H; Aizawa S; Shimono A
    Genesis; 2008 Feb; 46(2):92-103. PubMed ID: 18257070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization.
    Yin YJ; Katz V; Salah Z; Maoz M; Cohen I; Uziely B; Turm H; Grisaru-Granovsky S; Suzuki H; Bar-Shavit R
    Cancer Res; 2006 May; 66(10):5224-33. PubMed ID: 16707447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression.
    Midorikawa Y; Yamamoto S; Tatsuno K; Renard-Guillet C; Tsuji S; Hayashi A; Ueda H; Fukuda S; Fujita T; Katoh H; Ishikawa S; Covington KR; Creighton CJ; Sugitani M; Wheeler DA; Shibata T; Nagae G; Takayama T; Aburatani H
    Cancer Res; 2020 Sep; 80(18):3810-3819. PubMed ID: 32641413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma.
    Kongkham PN; Northcott PA; Croul SE; Smith CA; Taylor MD; Rutka JT
    Oncogene; 2010 May; 29(20):3017-24. PubMed ID: 20208569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hypermethylation and regulation of expression of secreted frizzled-related protein genes in colorectal tumor].
    Qi J; Zhu YQ; Luo J; Tao WH; Zhang JM
    Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):842-5. PubMed ID: 18396643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway.
    Su HY; Lai HC; Lin YW; Liu CY; Chen CK; Chou YC; Lin SP; Lin WC; Lee HY; Yu MH
    Int J Cancer; 2010 Aug; 127(3):555-67. PubMed ID: 19957335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concurrent Hypermethylation of
    Wang H; Duan XL; Qi XL; Meng L; Xu YS; Wu T; Dai PG
    Mol Cells; 2017 Jan; 40(1):45-53. PubMed ID: 28152305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.
    Huang J; Zhang YL; Teng XM; Lin Y; Zheng DL; Yang PY; Han ZG
    BMC Cancer; 2007 Jul; 7():126. PubMed ID: 17626620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased expression and aberrant hypermethylation of the SFRP genes in human gastric cancer.
    Kinoshita T; Nomoto S; Kodera Y; Koike M; Fujiwara M; Nakao A
    Hepatogastroenterology; 2011; 58(107-108):1051-6. PubMed ID: 21830441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.
    Kohno H; Amatya VJ; Takeshima Y; Kushitani K; Hattori N; Kohno N; Inai K
    Oncol Rep; 2010 Aug; 24(2):423-31. PubMed ID: 20596629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia.
    Cheng CK; Li L; Cheng SH; Ng K; Chan NP; Ip RK; Wong RS; Shing MM; Li CK; Ng MH
    Blood; 2011 Dec; 118(25):6638-48. PubMed ID: 22031861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
    Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.